Telix Pharmaceuticals Ltd — Capital/Financing Update 2026

May 7, 2026

Appendix 2A - Application for quotation of securities

Announcement Summary

Entity name
TELIX PHARMACEUTICALS LIMITED

Announcement Type
New announcement

Date of this announcement
Friday May 08, 2026

The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

ASX +security code	Security description	Number of +securities to be quoted	Issue date
TLX	ORDINARY FULLY PAID	264,943	08/05/2026

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

---

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

1.1 Name of entity
TELIX PHARMACEUTICALS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type
ACN
Registration number
616620369

1.3 ASX issuer code
TLX

1.4 The announcement is
New announcement

1.5 Date of this announcement
8/5/2026

Appendix 2A - Application for quotation of securities

---

Appendix 2A - Application for quotation of securities

Part 2 - Type of Issue

2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details:
| Announcement Date and Time | Announcement Title | Selected Appendix 3B to submit quotation request |
| --- | --- | --- |
| 13-Jan-2025 08:32 | New - Proposed issue of securities - TLX | A placement or other type of issue |

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No

Appendix 2A - Application for quotation of securities

---

Appendix 2A - Application for quotation of securities

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Placement Details

ASX +security code and description
TLX : ORDINARY FULLY PAID

Issue date
8/5/2026

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

| Number of +securities held | Number of holders | Total percentage of +securities held
For example, to enter a value of 50%
please input as 50.00 |
| --- | --- | --- |
| 1 - 1,000 | | % |
| 1,001 - 5,000 | | % |
| 5,001 - 10,000 | | % |
| 10,001 - 100,000 | | % |
| 100,001 and over | | % |

Appendix 2A - Application for quotation of securities

---

Appendix 2A - Application for quotation of securities

Issue details

Number of +securities to be quoted
264,943

Are the +securities being issued for a cash consideration?
No

Please describe the consideration being provided for the +securities
Consideration Shares for the acquisition of ImaginAb, Inc - refer Appendix 3B of 13 January 2025 and ASX Announcements of 13 January 2025 and 31 January 2025.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted
24.374500

Any other information the entity wishes to provide about the +securities to be quoted
264,943 shares issued for the holdback consideration of US$4 million on conclusion of the 15 month indemnity period, with no substantiated claims by Telix above a threshold amount. The calculation methodology in respect of the number of shares issued is set out in the Appendix 3B of 13 January 2025.

Appendix 2A - Application for quotation of securities
5 / 7

---

Appendix 2A - Application for quotation of securities

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

ASX +security code and description	Total number of +securities on issue
TLX: ORDINARY FULLY PAID	339,378,831

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

ASX +security code and description	Total number of +securities on issue
TLXAY: DEFERRED SHARE RIGHTS	66,140
TLXAX: DEFERRED SHARE RIGHTS EX-US	60,528
TLXAQ: SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAZ: SHARE RIGHTS US	384,500
TLXAR: PERFORMANCE RIGHTS	9,965,235
TLXAP: SHARE RIGHTS	1,289,754
TLXAO: SHARE APPRECIATION RIGHTS	13,417,272
TLXAT: CONVERTIBLE NOTES	6,250
TLXAM: OPTION EXPIRING 20-JUL-2026 EX $5.37	175,000
TLXAN: SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAU: DEFERRED SHARE RIGHTS EX-US 2024	9,450
TLXAW: PERFORMANCE SHARE APPRECIATION RIGHTS US 2025	4,275,702
TLXAS: PERFORMANCE SHARE INCENTIVE RIGHTS	440,000

Appendix 2A - Application for quotation of securities

---

Appendix 2A - Application for quotation of securities

Appendix 2A - Application for quotation of securities
7 / 7